State of the art: the treatment of systemic lupus erythematosus

Costanzo G.
Primo
Conceptualization
;
2024-01-01

Abstract

Purpose of reviewSystemic lupus erythematosus (SLE) is a systemic autoimmune disease with dysregulated cells in the immune system. The disease affects organs like kidneys, nervous system, joints, and skin. To manage SLE effectively, novel treatments targeting immune system components have been developed. This review investigates the therapeutic potential of existing targeted therapies and explores future innovative approaches for well tolerated, personalized treatment.Recent findingsSLE treatment involves cytokine targets and specific immunologic pathways, with even small molecules involved.SummaryThe advanced therapeutic options in SLE management give clinicians more tools to control disease activity according to personalized medicine.
2024
Inglese
24
4
266
273
8
Esperti anonimi
internazionale
scientifica
anti-B lymphocyte; anti-interferon; immunosuppressive drugs; precision medicine; systemic lupus erythematous
Goal 3: Good health and well-being
no
Costanzo, G.; Ledda, A. G.; Sambugaro, G.
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
3
partially_open
File in questo prodotto:
File Dimensione Formato  
state_of_the_art__the_treatment_of_systemic_lupus.14 2.pdf

Solo gestori archivio

Tipologia: versione editoriale
Dimensione 779.16 kB
Formato Adobe PDF
779.16 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
CostACI240411 (1).pdf

accesso aperto

Tipologia: versione post-print
Dimensione 1.12 MB
Formato Adobe PDF
1.12 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Questionario e social

Condividi su:
Impostazioni cookie